HomeJSPR • NASDAQ
Jasper Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 21.80M | 44.65% |
Net income | -21.24M | -54.73% |
Net profit margin | — | — |
Earnings per share | -1.41 | -37.16% |
EBITDA | -21.52M | -45.58% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 48.80M | -58.81% |
Total assets | 57.60M | -54.27% |
Total liabilities | 15.35M | 20.58% |
Total equity | 42.24M | — |
Shares outstanding | 15.02M | — |
Price to book | 1.73 | — |
Return on assets | -79.28% | — |
Return on capital | -100.64% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -21.24M | -54.73% |
Cash from operations | -22.84M | -45.16% |
Cash from investing | 4.00K | 116.00% |
Cash from financing | — | — |
Net change in cash | -22.84M | -172.30% |
Free cash flow | -17.20M | -52.78% |
Previous close
$4.85
Day range
$4.68 - $4.89
Year range
$3.14 - $26.84
Market cap
71.93M USD
Avg Volume
171.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2019
Headquarters
Website
Employees
64
